Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase

• Nelson S. Yew ,

  * E-mail: nelson.yew@genzyme.com

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Hongmei Zhao,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Eun-Gyoung Hong,

  Affiliations Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Endocrinology and Medicine, Hallym University College of Medicine, Seoul, South Korea

  ⨯
• I-Huan Wu,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Malgorzata Przybylska,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Craig Siegel,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• James A. Shayman,

  Affiliation Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Cynthia M. Arbeeny,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Jason K. Kim,

  Affiliations Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Canwen Jiang,

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯
• Seng H. Cheng

  Affiliation Genzyme Corporation, Framingham, Massachusetts, United States of America

  ⨯